

The Peter Attia Drive
Expert insight on health, performance, longevity, critical thinking, and pursuing excellence. Dr. Peter Attia (Stanford/Hopkins/NIH-trained MD) talks with leaders in their fields.
Episodes


#189 - COVID-19: Current state of affairs, Omicron, and a search for the end game

Iñigo San Millán, Ph.D.: Zone 2 Training and Metabolic Health (Ep. #85 Rebroadcast)
Mitochondrial function serves as the epicenter of metabolic health, where elite endurance athletes exhibit a level of efficiency that provides a blueprint for understanding and treating metabolic diseases like type 2 diabetes. Zone 2 training acts as a primary stimulus for slow-twitch muscle fibers, enhancing mitochond...

#188 - AMA #30: How to Read and Understand Scientific Studies

#187 - Sam Apple: The Warburg Effect—Otto Warburg's cancer metabolism theory

#186 - Patrick Radden Keefe: The opioid crisis—origin, guilty parties, and the difficult path forward

#185 - Allan Sniderman, M.D.: Cardiovascular disease and why we should change the way we assess risk

Rick Johnson, M.D.: Metabolic Effects of Fructose (Ep. #87 Rebroadcast)

#184 - AMA #29: GLP-1 Agonists—The Future of Treating Obesity?

#183 - James Clear: Building & changing habits

#182 - David Nutt: Psychedelics & Recreational Drugs

#181 - Robert Gatenby, M.D.: Viewing cancer through an evolutionary lens and why this offers a radically different approach to treatment

#180 - AMA #28: All things testosterone and testosterone replacement therapy

#179 - Jeremy Loenneke, Ph.D.: The science of blood flow restriction—benefits, uses, and what it teaches us about the relationship between muscle size and strength

#178 - Lance Armstrong: The rise, fall, and growth of a cycling legend

#177 - Steven Rosenberg, M.D., Ph.D.: The development of cancer immunotherapy and its promise for treating advanced cancers

#176 - AMA #27: The importance of muscle mass, strength, and cardiorespiratory fitness for longevity

#175 - Matt Kaeberlein, Ph.D.: The biology of aging, rapamycin, and other interventions that target the aging process
This podcast explores the complexities of aging, contrasting molecular definitions with functional perspectives like frailty. Matt Kaeberlein, a leading aging researcher, joins Peter Attia to discuss the hallmarks of aging, the role of disease, and the challenges of translating interventions from animal models to human...

#174 - Lawrence Wright: The 20th anniversary of the 9/11 attacks: reflections on how they happened, and lessons learned and not learned

#173 - AMA #26: Continuous glucose monitors, zone 2 training, and a framework for interventions
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.
